BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 16286771)

  • 1. Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.
    de Roux N
    Horm Res; 2005; 64 Suppl 2():48-55. PubMed ID: 16286771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GnRH deficiency: new insights from genetics].
    Kottler ML; Hamel A; Malville E; Richard N
    J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH receptor and GPR54 inactivation in isolated gonadotropic deficiency.
    de Roux N
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):515-28. PubMed ID: 17161329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome.
    Karges B; Roux N
    Endocr Dev; 2005; 8():67-80. PubMed ID: 15722618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of hypogonadotropic hypogonadism.
    Bhagavath B; Layman LC
    Semin Reprod Med; 2007 Jul; 25(4):272-86. PubMed ID: 17594608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).
    Zenaty D; Bretones P; Lambe C; Guemas I; David M; Léger J; de Roux N
    Mol Cell Endocrinol; 2006 Jul; 254-255():78-83. PubMed ID: 16757108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
    Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.
    de Roux N; Genin E; Carel JC; Matsuda F; Chaussain JL; Milgrom E
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10972-6. PubMed ID: 12944565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
    Kim SH; Hu Y; Cadman S; Bouloux P
    J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights in the genetics of isolated hypogonadotropic hypogonadism.
    Iovane A; Aumas C; de Roux N
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U83-8. PubMed ID: 15554891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
    Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations.
    Salenave S; Chanson P; Bry H; Pugeat M; Cabrol S; Carel JC; Murat A; Lecomte P; Brailly S; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2008 Mar; 93(3):758-63. PubMed ID: 18160472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolated hypogonadotropic hypogonadism].
    Shozu M
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():202-6. PubMed ID: 16689309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
    Brioude F; Bouvattier CE; Lombès M
    Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
    Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
    Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic anomalies of the gonadotropic axis].
    de Roux N; Morel Y; Hardelin JP
    Rev Prat; 1999 Jun; 49(12):1277-82. PubMed ID: 10488658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetics of Kallmann syndrome: an update].
    Fu C; Feng Z; Liu RZ
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.